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 Abstract 
 
Neurophysiologic intraoperative monitoring (NIOM) has been widely used during 
surgical procedures in hopes of preserving cranial nerve function and achieving 
better postoperative outcomes for patients.  Audiologists have contributed greatly 
to the field of NIOM for many years.  Many pharmacological agents used to induce 
sedation and anesthesia, along with a variety of other factors, such as gender, age, 
and body temperature changes that occur during surgery have been shown to 
impact auditory evoked potential recordings.  Knowledge of the various effects of 
anesthesia can better prepare audiologists to recognize and correct for changes that 
may occur as a result of anesthetics used during surgery.  Therefore, a single 
reference of normative data pertaining to anesthesia should be developed as a 
source for audiologists pursuing or practicing a career in NIOM.  Expert knowledge 
of anesthetics and their effects on evoked potentials will improve intraoperative 
patient care and strengthen the audiologist’s claim to the field of NIOM. 
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Chapter 1: Introduction 
 
Neurophysiologic intraoperative monitoring (NIOM) of cranial nerve activity 
has been widely used during surgical procedures to assess the functional integrity of 
the nervous system in hopes of preserving cranial nerve function and achieving 
better postoperative outcomes for patients (Edwards & Kileny, 2005).  Many 
procedures performed by head and neck surgeons, otologists, and neurotologists 
involve the exposure of cranial nerves, particularly the auditory nerve (AN), putting 
these structures at risk for iatrogenic injury (Marcus et al., 2003).  As a result, the 
field of audiology has contributed to the subspecialty area of intraoperative 
neurophysiologic monitoring by performing a variety of clinical tests to assist in the 
preservation of the AN and surrounding cranial nerves (Edwards & Kileny, 1998).  
Audiologists perform tests including electrocochleography (ECoG), designed to 
reveal immediate changes in cochlear function and the auditory brainstem response 
(ABR) (Edwards & Kileny, 1998).   
Clinically, the ABR can be used to measure hearing sensitivity in order to 
estimate behavioral auditory thresholds when these cannot be measured by 
traditional methods, such as hand-raising, due to the age or developmental status of 
the patient.  The ABR can also be used as a measure of neural synchrony, to assess 
the integrity of the AN and auditory brainstem neurons (Norrix et al., 2012).  For 
normal developmentally functioning adolescents and adults, ABR recordings can be 
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performed under ideal non-invasive, quiet conditions.  However, infants, children, 
and adults with developmental disorders or neuromuscular disease, and those 
undergoing surgical procedures may require sedation, anesthesia, or both.  
Consequently, many pharmacological agents used to induce sedation and anesthesia 
have been shown to impact auditory evoked potential recordings in animals 
(Ruebhausen et al., 2012; Stronks et al., 2010; van Looij et al., 2004), as well as in 
humans (Norrix et al., 2012; Manninen et al., 1985; Dubois et al., 1982.)  Along with 
a variety of other factors, such as gender, age, and temperature changes that occur 
during surgery, various anesthetic drugs have been linked to reductions in ABR 
amplitude (Stronks et al., 2010), as well as increases in neural conduction time 
(Dubois et al., 1982; Thorton et al., 1983; Manninen et al., 1985; Markand et al., 
1987; Schwender et al., 1995) resulting in delayed ABR absolute and interpeak 
latencies (Norrix et al., 2012).  Because pharmacological drugs used to induce 
sedation and anesthesia have been shown to alter the physiologic state of the animal 
and human, precautionary measures should be taken to ensure that the validity of 
auditory evoked potential recordings is not compromised during surgical 
procedures.   
Furthermore, knowledge of the various effects of anesthesia can better 
prepare audiologists performing intraoperative neurologic monitoring to recognize 
and correct for changes that occur in auditory evoked potential recordings and 
ultimately improve short and long-term outcomes for patients.  The purpose of the 
current review is to provide a detailed overview of anesthetic agents that have been 
shown to influence auditory evoked potential recordings and to outline their effects 
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to better prepare audiologists interpreting sedated ABR recordings or performing 
NIOM in recognizing and correcting for changes that can occur as a result of 
anesthesia. 
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Chapter 2: Auditory Evoked Responses and their Contribution to Neurophysiologic 
Intraoperative Monitoring 
 
 
 
The chief purpose of monitoring auditory evoked potentials during surgery is 
to reduce the risk of injury to the eighth cranial nerve (CN VIII) (Møller, 2011).  
Surgeries that can jeopardize the health of the intact CN VIII include vestibular 
schwannoma resection, microvascular decompression to relieve trigeminal 
neuralgia, hemifacial spasm, glossopharyngeal neuralgia (Grundy, 1983; Møller & 
Janetta, 1983), and operations on CN VIII in patients with tinnitus and disabling 
positional vertigo (Møller & Møller, 1989).   Preservation of auditory function has 
improved over time due not only to advancements in surgical techniques, but also 
through the introduction of intraoperative neurophysiologic monitoring of the AN 
(Colletti et al., 1994; Silverstein et al., 1984; Fisher, 1989; Linden et al., 1988; Kuroki 
& Møller, 1995; Møller et al., 1994). 
Auditory Component of Eighth Cranial Nerve 
The auditory nerve plays a vital role within the auditory system.  It functions 
to carry electrical impulses from the cochlea to the brainstem.   Once auditory 
information has been coded within the cochlea it passes through the AN and onto 
the brain.  Along the way, frequency and intensity characteristics of sounds are 
coded by the AN.  AN fibers are tonotopically organized with high-frequency fibers 
located on the outermost portion of the nerve, the mid-frequencies located medially 
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to the high-frequency fibers, and low-frequency fibers located on the innermost 
portion of the nerve, thus preserving the tonotopicity established in the cochlea.  AN 
fibers are connected to hair cells that run from the basal to the apical end of the 
cochlea and are spatially organized from high to low frequencies.  Frequency is 
coded by place and firing rate characteristics of the AN fibers.  Low frequencies are 
represented by low firing rates and high frequencies by high firing rates.  Phase-
locking capabilities of the AN allow it to lock onto cycles of sound waves causing the 
AN to fire synchronously with auditory stimuli.  Intensity is also coded at the level of 
the AN.  This is done using the number of fibers involved (more for higher 
intensities) and the firing rate of the nerve fibers, which is greater for high 
frequency sounds (Musiek & Baran, 2007). 
Vestibular Component of Eighth Cranial Nerve 
The other component of the CN VIII, the vestibular component, also plays a 
fundamental role in human sensory perception.  Afferent fibers of the vestibular 
portion of CN VIII are located within the internal auditory canal near the entrance of 
CN VIII into the cerebollopontine angle (CPA) (Brodal, 1981).  The vestibular 
labyrinth consists of five neural structures that detect head acceleration.  These 
consist of three semicircular canals and two otolith organs.  Two types of hair cells 
exist in the peripheral vestibular system.  Afferent information travels from these 
hair cells located in the vestibular labyrinth ipsilaterally through one of two 
branches of the vestibular portion of CN VIII.  The superior branch innervates the 
horizontal and anterior semicircular canals as well as the utricle otolith organ.  The 
inferior vestibular nerve innervates the posterior semicircular canal along with the 
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saccule otolith organ (Naito et al., 1995).  Damage to CN VIII can manifest with both 
auditory and vestibular symptoms.  Therefore, preservation of the integrity of CN 
VIII after injury or infection is important not only for maintaining auditory function, 
but for maintaining vestibular function as well. 
Non-surgical Injury to Auditory Nerve 
In addition to surgical injury for which NIOM can be used, AN fibers are 
vulnerable to damage by infection, disease, trauma, and medication.  The main 
clinical pathology of CN VIII is the acoustic neuroma, which is most often a 
vestibular schwannoma, arising from the Schwann cells surrounding the sheath of  
CN VIII (House et al., 1997).  These benign tumors can be dangerous because they 
can grow largely into the CPA and lie in close proximity to the brainstem (Lustig & 
Jackler, 1977).  These tumors first approach the outside of the AN, causing damage 
to high-frequency fibers, which is why high-frequency hearing loss is one of the 
initial signs of an acoustic neuroma (Johnson, 1977).  CN VIII tumors disrupt the 
function of the AN by slowing or preventing nerve impulses that travel along its 
axons.  Reducing the speed of these impulses can cause dys-synchrony and impair 
the transmission of complex sounds across the nerve.  This will also lead to latency 
delays of the ABR, or the complete loss of ABR waves.  Another form of schwannoma 
is neurofibromatosis.  Neurofibromatosis type 2 (NF2) is characterized by bilateral 
cochleovestibular schwannomas and progressive hearing loss.  In addition to 
schwannomas, other tumor types including lipomas and meningiomas, can affect the 
AN and where the nerve enters the brainstem at the CPA.   
Although tumors of the AN are the most prominent disorder of the AN, 
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vascular and viral lesions can also result in AN dysfunction (Møller, 2000).   Cysts 
and aneurysms, as well as other disease processes including cochlear neuronitis, 
diabetic cranial neuropathy, and auditory neuropathy/ dys-synchrony can 
compromise the function of the AN.  Although rare, inflammation of CN VIII can 
result from a viral attack on the cochlear portion of the nerve, causing degeneration 
of cochlear neurons, along with sudden and severe hearing loss.  Furthermore, 
neuropathy as a result of insulin deficiency is common in diabetes mellitus patients 
and can cause vestibular pathologies and retrocochlear hearing loss.  Auditory 
neuropathy is a CN VIII pathology, which results in a loss of synchrony of neural 
firing (Berlin et al., 2001).  The exact cause of auditory neuropathy/ dys-synchrony 
is often unknown, however the integrity of the AN can be affected by lack of 
auditory input to the cochlea, as in cases of severe to profound sensorineural 
hearing loss, resulting in neural degeneration (Musiek & Baran, 2007). 
Surgical Injury to Auditory Nerve 
Aside from infection and disease, trauma occurring during surgical 
procedures is a source of damage to CN VIII.  AN compromise during surgery can 
take place by way of direct injury to the internal auditory artery or labyrinthine 
artery or by stretching or compression of CN VIII itself.  Direct trauma can also 
result from drilling as well as transection of CN VIII.  Thermal injury can further 
result by cautery or laser use during surgery (O’Malley et al., 2006). While most of 
the CN VIII pathologies discussed above cannot be predicted or prevented, surgical 
injuries are unique CN VIII pathologies because they are largely preventable with 
proper NIOM. 
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Auditory Evoked Potential Recording Tests employed in NIOM 
NIOM of AN integrity during surgery can be done using a variety of evoked 
potentials techniques.  When large numbers of AN fibers fire synchronously, evoked 
potentials can be recorded from the AN.  By delivering an abrupt acoustic stimulus, 
the auditory system’s response is generated as a series of neuroelectrical responses.  
Auditory evoked potential recordings can be obtained using near-field electrodes 
placed on or close to the AN or using far- field electrodes placed on the head 
(Musiek & Baran, 2007).  The earliest responses occur within the first 10 
milliseconds and are considered short-latency auditory evoked responses (Zamel, 
2010).  These responses can be recorded from the vicinity of the cochlea using 
electrocochleography (EcochG), at the level of the auditory brainstem using the ABR 
recorded from electrodes placed on the scalp, or by direct recording of the 
compound action potential (CAP) from the CN VIII while it is exposed during 
surgery (Møller, 2006).   
Electrocochleography (EcochG) 
EcochG is a technique of measuring electrical potentials generated within the 
cochlea and can be performed for NIOM by placing electrodes at the tympanic 
membrane or trans-tympanically within the middle ear space (Schlake et al., 2001 
Zamel, 2010).  The trans-tympanic method is used commonly for auditory 
monitoring in vestibular schwannoma resection procedures (Levine et al., 1978; 
1984).  Changes observed in EcochG potentials can imply that blood supply to the 
ear has diminished due to labyrinthine artery damage, at which point monitoring 
can no longer prevent permanent hearing damage.  Also, because the EcochG 
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potentials reflect only the action potentials of the distal portion of the AN fibers, and 
the risk of damage in these surgical procedures lies in the intracranial portion of the 
nerve, monitoring by way of EcochG is limited in its usefulness (Møller, 2011). 
Auditory Brainstem Response (ABR) 
The ABR includes the actions potentials of the AN fibers (Wave I of the ABR) 
and adds several components that arise from later auditory brainstem structures.  
The remaining responses all typically occur within the first 10 milliseconds and 
reflect the conduction of stimuli through auditory pathways, as well as convey 
valuable information concerning the general function of the brainstem.  The 
brainstem is  comprised of three structures, each serving specific functions vital to 
survival. The brainstem is responsible for regulating respiration, heart rate and 
blood pressure, all of which remain fundamental to organism survival.  An impaired 
brainstem can mean death for a patient. Therefore, monitoring of the brainstem 
during surgical procedures proves to be essential in maintaining the status of the 
living patient (Bhatnagar, 2008).   
 The auditory portions of the brainstem represent physiologically-accessible 
points that can be monitored relatively easily and non-invasively.  The ABR consists 
of a series of peaks, labeled as waves, which are thought to originate from specific 
generator sites within the  the peripheral auditory system and the brainstem. Waves 
I and II originate from the AN, Wave I from the more distal portion of CN VIII, and 
Waves III-V are generated as a result of neural functioning from the level of the 
brainstem (Møller & Jannetta, 1982; Møller et al., 1981). The brainstem plays a 
crucial role in the auditory system.  Located within the brainstem are three groups 
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of nuclei that convey auditory information from the AN to higher regions of the 
central auditory nervous system (CANS).  The first location with the CANS is the 
cochlear nucleus (CN).  The CN is located in the caudal pons (Musiek & Baran, 2007).  
The cells of the CN preserve the neural firing pattern of the AN (Pfeiffer, 1966) 
therefore maintaining frequency representation.  The CN’s neurons can fire at high 
rates allowing for precise temporal coding ability.  With respect to evoked 
potentials, the CN contribute to Wave III of the ABR, which occurs approximately 2 
milliseconds after Wave I. Wave III has a relatively large amplitude in normal 
hearing patients (Møller, Jannetta, & Jho, 1994). 
The next major group of auditory nuclei in the brainstem is located deep 
within the pons and makes up the superior olivary complex (SOC).  Like the CN, a 
tonotopic arrangement of auditory nuclei is carried on through the SOC.  
Furthermore, the SOC is the first place in the auditory system in which auditory 
input is represented bilaterally.  At this point, ipsilateral acoustic input can cross 
over permitting the comparison of contralateral and ipsilateral auditory input.  
These complex comparisons of temporal and intensity information then allows for 
key functions of the SOC, such as fusion, lateralization, and localization to be carried 
out.  Fusion involves combining and integrating acoustic information arriving at 
both ears.  The SOC is also highly sensitive to interaural time and intensity 
differences, providing the basis for lateralization and localization abilities of the 
auditory system (Musiek & Baran, 2007).  In regards to the ABR waveform, the SOC 
contributes a strong response, which is believe to form Wave IV of the ABR (Møller 
et al., 1995). 
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The third group of auditory nuclei located throughout the auditory pathway 
in the brainstem is the lateral lemniscus (LL).  This group of nuclei is located in the 
upper pons (Musiek & Baran, 2007).  The tonotopic arrangement of the LL is not 
well understood, however it is known that the LL is sensitive to time and intensity 
differences and may contribute to localization abilities (Brugge, Anderson, and 
Aitkin, 1970).  In reference to the ABR, the LL is a key contributor.  It is known that 
the lateral lemniscus is the generator site mostly responsible for Wave V of the ABR 
(Møller, 2000).   
    The latencies and amplitudes of ABR waves are sensitive to physical injury 
to the structures that generate them.  During surgical manipulation, it is mainly 
changes in latency values of the ABR wave components or the CAP from the AN that 
are used as evidence of CN VIII injuries.  Amplitude changes in the ABR waveform 
are also red flags indicating surgically-induced injuries (Hatayama & Møller, 1998).  
During ABR monitoring, thorough and cautious assessment in the recordings for 
ABR pattern changes and their relationship to the surgical maneuvers being done 
are used in determining whether damage is being done or already occurred to the 
AN or brainstem (Zamel, 2010). 
 While interpretation of the ABR is complex, changes in CAP recordings taken 
directly from CN VIII can offer more exact, targeted evidence of AN impairment from 
surgical injury.  ABR recordings during surgery must be compared to baseline 
recordings in the same patient performed preoperatively (Møller, 2011).  Therefore, 
direct recording of the CAP provides advantages over ABR recordings in that it 
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allows for instantaneous feedback for changes occurring in the condition of the AN 
(Zamel, 2010).   
According to the American Clinical Neurophysiology Society (2006) criteria, 
monitoring standard auditory evoked potentials involves the monitoring of the two 
main variables of latency and amplitude.  Absolute latencies and interpeak intervals 
are the most reliable parameters used in the monitoring of the ABR, and 
interpretation of Waves I, III, and V are considered the most reliable peaks within 
the waveforms.  Wave V is predominately the easiest wave to identify.  Thus, 
changes in this wave’s absolute latency, as well as changes in the Wave I-V interpeak 
interval are generally used to predict hearing loss during surgery.   
Latency and amplitude values obtained throughout surgery are continuously 
compared using the same acquisition and stimulus parameters to the patient’s own 
baseline ABR completed prior to the surgery (Zamel, 2010). Although there is no 
standard, the most commonly used latency criteria for warning the surgeon of 
possible CN VIII damage is a 1 millisecond delay in Wave V latency (Watanabe et al., 
1989; Manninen et al., 1994).  Alternative criteria include the complete 
disappearance of Wave V as an indication of possible hearing loss (Grundy et al., 
1983; Friedman et al., 1995; Schlake et al., 2001) or a delay in Wave V of only 0.5 
milliseconds or more (Coletti et al., 1998).  James and Husain (2005) suggest that 
the criteria used to interpret Wave V latency changes should be done on an 
individual basis depending on the underlying pathology and the type of surgery.  
The lack of universal guidelines for interpreting latency changes is well recognized 
and acceptable due to the possibility of rigid criteria leading to unnecessary 
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warnings to the surgeon.  However, it remains of upmost importance to notify the 
surgeon when steady decline of the waveform or latencies occurs even if the latency 
threshold criteria are not met (Zamel, 2010). 
Unlike latency values, measures of peak amplitude vary considerably 
between patients.  Therefore, amplitude of a waveform peak alone is not used as a 
criterion to interpret possible hearing loss during surgery (Zamel, 2010).  In NIOM, 
ABR Wave amplitudes remain relatively consistent within the same patient (Zamel, 
2010), however, the ratio of amplitudes of Waves V/I has been shown to be more 
constant (Tusa et al., 1994) than individual peak amplitudes, and amplitude ratio of 
Waves V/I has been shown to indicate injury to auditory pathways earlier or 
without any change in latency values.  Likewise, Hatayama and Møller (1998) found 
amplitude of Wave V to be more sensitive at identifying hearing loss than latency.  
Criteria used for amplitude include a greater than 50% drop in Wave V amplitude, 
while others have argued that only a complete disappearance of Wave V can be a 
predictor of hearing loss (James & Husain, 2005). 
Middle and Long-latency Auditory Evoked Potential Responses 
Middle and long-latency auditory potentials are also produced in response to 
brief acoustic stimuli.  The Auditory Middle Latency Response (AMLR) has a latency 
of 10 to 50 milliseconds and consists of three main positive and negative 
components, or peaks: Na, Pa, and Nb, with a second positive peak, Pb, sometimes 
present.  The AMLR is the auditory evoked potential most commonly used to 
measure the effects of anesthesia and is highly sensitive to anesthetic agents, which 
is why this auditory evoked potential is not routinely used for clinical 
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neurophysiologic monitoring (Zamel, 2010).  Succeeding the AMLR are late or long- 
latency auditory potentials.  These evoked responses are mainly generated at the 
level of the cerebral cortex also making them exceptionally vulnerable to the effects 
of anesthesia.  Because of this, later cortical responses, along with AMLR are not 
appropriate for the purposes of NIOM (Zamel, 2010). 
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Chapter 3: Types of Anesthesia and Associated Mechanisms of Action 
 
In order to appreciate the effects of anesthesia on the ABR and other auditory 
evoked potentials, an explanation of the various types of sedatives and anesthetics 
and the mechanisms by which each operates is warranted.   
Sedation versus Anesthesia 
Depending on the type and goal of the procedure being performed, sedation, 
anesthesia, or a combination of both are induced in the patient.  Sedation involves 
the depression of the central nervous system to generate relaxed and diminished 
responsiveness without inducing sleep and maintaining a particular level of 
consciousness (Elrich & Schroeder, 2012).  Contrary to sedatives, anesthesia 
involves the absence of normal sensation, particularly that of pain by producing a 
level of unconsciousness sufficient to suppress the awareness of the surgical 
procedure (Smith, 1994).   
From the perspective of NIOM, sedation may be used in conjunction with 
anesthesia during major surgical procedures in order to reduce the amount of 
noxious anesthetics used in a balanced anesthesia method (Zavisca, 1994).  
However, from a diagnostic audiologic standpoint, sedation is mainly used in the 
application of ABRs when reliable results in the measurement of hearing sensitivity 
cannot be obtained through traditional behavioral methods (Avlonitou et al., 2011; 
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Pillion et al., 2010).  Sedation is used in populations including infants, young 
children (Avlonitou et al., 2011), and individuals with developmental disabilities to 
reduce myogenic activity that can interfere with the auditory evoked potential 
recording (Pillion et al., 2010).  Sedated ABRs can be performed in clinical settings 
or the operating room with an anesthesiologist present.  During surgical procedures 
for which NIOM is employed, sedatives such as barbiturates and benzodiazepines 
are used as an adjunct to anesthetics and analgesics.  Conversely, for diagnostic 
sedated ABRs, chloral hydrate is widely used as an oral sedative hypnotic in 
pediatric and developmentally disabled populations (Avlonitou et al., 2011). 
Types of Anesthesia 
Anesthesia may be applied topically, regionally, locally, or generally.  Topical 
anesthesia serves to numb only the tissue surface and can be used in the form of a 
liquid, ointment, or spray.  Regional anesthesia involves the temporary interruption 
of neural conduction and is induced by injection of an anesthetic near the nerves to 
be blocked.  Spinal and epidural anesthesia are examples of regional anesthesia.  
This type of anesthesia provides numbness while the patient maintains 
consciousness.  Local anesthesia causes a loss of sensation within a restricted area, 
and like regional anesthesia, is produced by injection of an anesthetic near the 
target area (Elrich & Schroeder, 2012).   Local anesthetics include lidocaine, 
bupivacaine, cocaine, and tetracaine.  This type of anesthesia is often used during 
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minor surgeries on the oral cavity, which require peripheral nerve block in which 
only the surgical site is anesthetized and conscious sedation is maintained (Rassias 
& Procopio, 2003).  Local and regional anesthetics are not commonly utilized during 
auditory surgeries. 
General Anesthesia 
For the purpose of major surgical procedures, including most procedures 
affecting the AN or CANS where NIOM takes place, general anesthesia is utilized.  
General anesthesia entails a total loss of bodily sensation and consciousness.  
General anesthesia functions to provide unconsciousness, amnesia, analgesia, and 
muscle relaxation, while maintaining homeostasis of physiologic function during 
surgery.   General anesthesia can be induced by means of inhalation or intravenous 
injection.  Inhalational anesthetic agents exist as either gases or volatile liquids, 
which readily evapoarate to gaseous form.   The gas or vaporized liquid is combined 
with oxygen from a compressed gas cylinder in an anesthesia delivery machine, and 
then routed to the patient through a breathing mask or cone.  Gases include nitrous 
oxide and cyclopropane.  Among the volatile liquids used are halothane, enflurane, 
isoflurane, sevoflurane, and desflurane. General anesthetics can also be 
administered intravenously or intramuscularly in liquid form.  Propofol is 
commonly administered intravenously, and ketamine and xylazine are regularly 
given intramuscularly.  These three agents are also frequently used in  testing of the 
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auditory system in animals for experimental or clinical veterinary purposes.  In 
addition, adjuvant intravenous agents are used intraoperatively for pain control.  
These anesthetic- enhancing narcotic agents include opioids, such as morphine, 
demerol, vicodin, codein, nubain, and fentanyl, the most common opioid used 
clinically in the United States  (Rassias & Procopio, 2003). Neuromuscular blocking 
agents (NMBA) are also used in conjunction with inhaled and intravenous 
anesthetics, acting as sedatives to further prevent voluntary and reflex muscle 
movement during surgical procedures (Moore & Hunter, 2001).  Neuromuscular 
blocking agents include pancuronium, atracurium, mivacurium, and vecuronium 
(Zavisca, 1994). 
The ideal anesthetic agent would induce minimal cardiovascular and 
respiratory disruptions, would permit adequate oxygenation, and be nontoxic 
(Zavisca, 1994).  However, this is not the case with many important anesthetics. 
Many frequently utilized anesthetic agents have been known to cause myocardial 
depression, respiratory and cardiovascular depression, hepatotoxicity, and renal 
toxicity. Nitrous oxide is a powerful analgesic with minimal cardiovascular effects.  
Therefore, the addition of nitrous oxide to the anesthetic regiment being used 
allows for a decreased need of the more toxic agent, while still producing the same 
pain relieving effects.   Nitrous oxide is less soluble in tissues and allows for a more 
rapid awakening process for the patient.  Also, the use of added NMBAs, small 
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amounts of opioids for additional analgesia, and benzodiazepines for additional 
sedation and amnesia can reduce the amount of toxic anesthetic needed.  This 
technique is called balanced anesthesia (Zavisca, 1994).   
Stages of Anesthesia 
Galloway (2010) defined four stages of general anesthesia.  Galloway 
described a patient undergoing general anesthesia as passing through each distinct 
stage smoothly with the introduction of various anesthetic agents (2010).  The first 
stage is premedication, which serves to relieve the patient of anxiety and help the 
patient relax.  The premedication stage employs the use of intravenous 
benzodiazepines, such as versed, or can include a narcotic, such as morphine or 
fentanyl for pain.  The second stage is induction.  Induction of anesthesia is done 
using an intravenous bolus of sedative and hypnotic agents.  Often times, an 
intravenous opioid and neuromuscular relaxant or paralytic agent are administered.  
Monitoring of evoked potentials is likely to be avoided during this stage due to a 
bolus of anesthetic being likely to cause smaller amplitude cortical responses, rather 
than a lessened anesthetic effect seen with controlled infusions of anesthetic agents 
as observed in the third stage of anesthesia. The third stage is the maintenance of 
anesthesia.  The maintenance stage makes up the majority of the surgical procedure.  
To sustain an anesthetic state throughout surgery, ongoing sedative hypnotic agents 
are used in conjunction with a volatile anesthetic or nitrous oxide in combination 
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with an opioid agent.  The fourth and final stage is emergence from anesthesia.  
Emergence is carried out by lessening the amount of the volatile agent and 
introducing oxygen for the reversal or wearing off of the volatile agent. 
Each pharmacologic agent used in the induction and maintenance of sedation 
and anesthesia produces different effects on the body, specifically the central 
nervous system.  Failure of synaptic transmission, and thus delayed nerve 
conduction caused by these various drugs, can be observed at the level of the CANS 
and measured by the audiologist during sedated ABR testing and auditory evoked 
potential recordings intraoperatively. 
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Chapter 4: Non-anesthetic Variables that Influence Auditory Evoked Potentials in 
Neurophysiologic Intraoperative Monitoring 
 
Anesthetic drugs and surgical injuries that affect the auditory nervous 
system are not the only likely cause for ABR waveforms to deviate from clinical 
norms.  Age, gender, and temperature effects on ABR amplitude and latency have 
been well documented.   
Age Effects 
ABR absolute and interpeak latencies are longer for the newborn and infant 
populations.  Adult-like latency values are not achieved until approximately two 
years of age (Hecox & Galambos, 1974; Salamy, 1984).  For this reason, age-specific 
normative data are used by clinicians when interpreting ABR waveforms within this 
population (Gorga et al., 1989; Issa & Ross, 1995).   Conversely, decreases in ABR 
amplitude and increases in latencies are commonly seen within the aging population 
(Jerger & Hall, 1980).  Because age-related changes can result in demyelination or 
reduced numbers or of neural structures within the ABR generators, the cochlea, AN 
and auditory brainstem, neural conduction time can increase and neural synchrony 
can decrease. Therefore, AN input and temporal processing at these levels can be 
compromised (Austin et al., 2012).  Moreover, age effects are also present in 
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response to anesthetic agents administered during ABR testing.  The geriatric 
population is more sensitive to anesthetic agents overall.  Lower amounts of  
anesthetic drugs are often required for older individuals to achieve similar effects 
that occur in younger individuals.  Effects of anesthetic drugs are also usually 
prolonged in older patients as compared to younger patients (Kanonidou & 
Karystianou, 2007). 
Gender Effects 
Gender effects on the ABR have also been consistently reported.  Adult 
females tend to exhibit ABRs with shorter absolute latencies, especially for later 
peaks, shorter interpeak latencies and larger response amplitudes compared to 
adult males (Dehan & Jerger, 1990).  The etiology of this observed gender difference 
has been attributed to a combination of head size differences, hormonal effects on 
neural transmission (Dehan & Jerger, 1990), better hearing sensitivity on average 
for females (Corso, 1963), and higher average body temperature in women (Elkind-
Hirsh et al., 1992).   Decreased ABR latencies have been observed in the female 
during periods of increases in the natural female steroid, estrogen, also shown to 
increase basal body temperature, during the menstrual cycle by speeding up neural 
conduction within the female (Elkind-Hirsh et al., 1992).   Differences in physical 
dimensions of the skull between males and females, with females having a smaller 
skull size on average, equate to less physical area for a an evoked electrical response 
to travel, resulting in auditory evoked potentials observed at earlier latencies in 
females (Dehan & Jerger, 1990).   
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Not only have gender differences been observed in ABR recordings, gender 
effects have been associated with differences in response to the anesthetic state in 
general (Gan et al., 1999; Myles et al., 2001).   Females have a higher body fat 
percentage  and decreased water content compared to males, which affect the 
volume of distribution of many drugs (Pleym, 2003). Several studies have failed to 
report clinically relevant gender differences for inhalational anesthetics such as 
isoflurane and halothane (Coetzee & Stewart, 2002; Katoh et al., 1993), sevoflurane 
(Katoh et al., 1993; Sarton et al., 1999), and desflurane (Greif et al., 2002).  However, 
gender effects have been reported for intravenous anesthetics such as propofol 
(Myles et al., 2001; Gan et al., 1999; Vuyk et al., 2001), opioid analgesics (Burns et 
al., 1989; Sidebotham et al., 1997; De Kock & Scholtes, 1991), and muscle relaxants 
(Semple et al., 1994; Donati & Bevan, 1999; Xue et al., 1997).   Studies have reported 
males to be more sensitive then females to propofol (Myles et al., 2001; Gan et al., 
1999; Vuyk et al., 2001), and decreasing the propofol dose by 30-40% when 
administered to males has been suggested in order to accomplish similar recovery 
times in males and females.  Studies have also shown females to be 20-30% more 
sensitive to the effects of the muscle relaxants vecuronium (Semple et al., 1994), 
pancuronium (Donati & Bevan, 1999), and rocuronium (Xue et al., 1997).  Similarly, 
research on gender differences in response to opioid analgesics has shown females 
to be more sensitive than males to opioids, particularly morphine (Burns et al., 
1989; Sidebotham et al., 1997; De Kock & Scholtes, 1991).  Therefore, males are 
required to receive 30-40% higher doses of opioid analgesics than females to attain 
the same pain relieving effects (Pleym, 2003). 
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Temperature Effects 
Additionally, body temperature changes caused by anesthesia during surgery 
have been associated with increased ABR latencies.  Anesthesia can cause 
vasodilation, which can then lead to decreased core body temperature and slow 
neural conduction time, resulting in increased ABR interpeak latencies (Markand et 
al., 1987).  Physiologic events that can occur during surgical procedures have also 
been shown to affect the ABR.  Local or systematic hypothermia can cause 
prolonged absolute and interpeak latencies and also wave amplitudes to diminish.  
Tissue compression and retraction can lead to abolished or degraded averaged 
auditory responses.  In addition, insufficient ventilation, hemodilution, systemic 
hypotension and regional ischemia can produce reduced oxygen effects on the 
endocochlear potential by causing decreased cochlear output (Edwards & Kileny, 
2005). 
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Chapter 5: Effects of Specific Anesthetic Agents on Auditory Evoked Potential 
Recordings 
 
 
 
A great deal of literature has investigated anesthetic and sedative effects on 
auditory evoked potential recordings.  The most common agents used throughout 
this literature are members of the general anesthesia family of volatile liquids, 
including isoflurane, sevoflurane, enflurane, and nitrous oxide, along with those 
most commonly used in animal studies, ketamine and xylazine, which are 
administered as intramuscular solutions.  General inhalation anesthetics, such as 
isoflurane, sevoflurane, enflurane, and nitrous oxide are often used because they 
demonstrate rapid induction and quick recovery time with little residual effects.  
Using inhalation anesthesia also provides the advantage of more precise regulation 
by allowing more immediate adjustment of the anesthetic level when the 
physiologic state of the human or animal is altered.  Ketamine and xylazine, 
however, require an induction time of several minutes and recovery time of several 
hours.  Furthermore, equipment for the administration of inhalation anesthetics is 
costly and waste gases can pose a hazard to laboratory or surgical environments 
and should be vented from these environments.  Equipment for the administration 
of ketamine and xylazine is less costly, but the use of a hypodermic needle and 
syringe requires more training for laboratory personnel (Ruebhausen et al., 2012).  
Several studies to date have looked at the influence of various anesthetic agents on 
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auditory evoked potentials, specifically the ABR.  Some studies have found that 
halogenated anesthetic agents affect the ABR in animals (Van Looij et al., 2004).   
as well as humans (Edwards & Kileny, 2005), while other study data have suggested 
that these agents cause prolongation of latencies of ABR components only at high 
concentrations (Galloway, 2010) .  Other studies (Møller, 2011; Edwards & Kileny, 
1997) have found no effects on the ABR by this group of anesthetics.  According to 
an article published by Stronks and colleagues (2010), general anesthetics, such as 
barbiturates (Shapiro et al., 1984; Drummond et al., 1985; Church & Shucard, 1987), 
ketamine (Church & Gritzke, 1987), and the halogenated volatiles (Dubois et al., 
1982; Sainz et al., 1987; Santarelli et al., 2003) typically increase ABR latency, 
especially that of the later peaks, and do not typically affect ABR amplitude, whereas 
nitrous oxide (Manninen et al., 1985) and the opioids, such as morphine and 
fentanyl (Samra et al., 1984) do not alter the ABR.  A detailed discussion of the 
effects of different anesthetics on auditory evoked potentials in humans and animals 
follows: 
Barbiturates 
Barbiturates are a class of drugs which function to depress the central nervous 
system and can be used as sedatives, hypnotics (sleep-inducing), and 
anticonvulsants to prevent seizures (Elrich & Schroeder, 2012).  Examples of 
barbiturates include thiopental, phenobarbital, and pentobarbital.  Studies by 
Stockard et al. (1977) and Duncan et al. (1979) both found barbiturates to have no 
influence on ABRs in humans.  A later study by (Newlon et al., 1983) also stated that 
barbiturate agents do not do not influence human ABRs.  Conversely, the barbiturate 
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pentobarbital was shown to increase CAP thresholds and latencies at high stimulus 
frequencies (Cazals et al., 1980).  Pentobarbital has also been reported to decrease 
cochlear microphonic (CM) amplitudes (Samara & Tonndorf, 1981).  Furthermore, 
pentobarbital in amounts greater than 9 mg/kg has been found to cause prolonged 
ABR latencies and reduced ABR amplitudes and the barbiturate agent thiopental has 
been shown to prolong Wave V latencies and reduce ABR amplitudes in doses 
greater than or equal to 20 mg/kg (Edwards & Kileny, 2005).   
Halothane  
Halothane is a volatile synthetic organic compound used as an inhalational general 
anesthetic.   Stockard et al. (1977) reported that halothane had no influence on 
ABRs in humans, and Duncan et al. (1979) reported that no effects of halothane 
were found in ABRs from children.   However, James et al. (1982) found that the use 
of halothane increased ABR latencies in adults.  
Nitrous Oxide 
Nitrous Oxide is a chemical compound in the form of a gas at room temperature, and 
is also commonly known as laughing gas.  It is used as an adjunct to general 
anesthesia for its analgesic effects (Zavisca, 1994).  Several studies have examined 
the effects of the addition of nitrous oxide to various concentrations of halogenated 
volatile anesthestics.   Manninen et al. (1985) studied the effects of the addition of 
50% nitrous oxide to isoflurane anesthesia in humans.  This study found that the 
addition of the nitrous oxide compound had no effect on ABRs.  These results are 
consistent with a previous study, reporting no change in latency with addition of 
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70% nitrous oxide to enflurane anesthesia in normal hearing patients (Rosenblum 
et al., 1982). 
Halogenated volatiles 
The effects of isoflurane on the ABR have been well documented.  Several studies on 
isoflurane effects in humans have shown increased latency of late ABR peaks, 
however the ABR amplitude was unaffected (Manninen et al., 1985; Sebel et al., 
1986; Lloyd-Thomas et al., 1990).  Manninen et al. (1985) studied the effects of 
isoflurane on the ABR in 10 healthy adults.  This study found isoflurane to increase 
the absolute latencies of Waves III, IV, and V significantly above awake control 
levels.  Manninen et al. (1985) also found that interpeak latencies were significantly 
increased as well.  The increase occurred at 1.0% end-tidal isoflurane and did not 
continue to further increase after 1.5% and 2.0% end-tidal isoflurane concentration.  
Edwards and Kileny (2005) report a general delay of 0.5-1.0 ms prolongation of ABR 
Wave V, as well as an increased I-V interpeak latency when end-tidal concentration 
exceeded 1.5% for inhalation anesthetics including isoflurane, enflurane, and 
halothane.  
Several animal studies have demonstrated increased latency and decreased 
amplitude effects on several ABR peaks after isoflurane administration (Santarelli et 
al., 2003; Stronks et al., 2010; Ruebhausen et al., 2012).  Isoflurane was also 
reported to attenuate cochlear evoked responses in Guinea pigs (Stronks et al., 
2010).  This study found isoflurane dose-dependently suppressed the amplitude and 
latency of the CAP and suppressed CM amplitude at 2.5% and 3% end-tidal 
concentrations.  These results are contradictory to those obtained in the 
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aforementioned Manninen et al. (1985) study, completed in a human population.  
The Manninen et al. (1985) study demonstrated a plateau effect, in which no further 
amplitude or latency delays were observed after 1.5% end-tidal concentration.   
This discrepancy can be possibly be attributed to differences in how the Guinea pig 
and human process isoflurane anesthesia.  Additionally, a study by Ruebhausen et 
al. (2012) found that hearing thresholds obtained under isoflurane anesthesia were 
elevated approximately 27 dB on average across all stimuli compared to those 
obtained under ketamine/xylazine anesthesia. 
Sevoflurane and enflurane, additional members of the halogenated volatile 
family have been used in studies of auditory evoked potentials.  Thorton et al. 
(1983) found that enflurane was linked to increased ABR wave latencies, especially 
in Waves III and V.  Norrix et al. (2012) retrospectively analyzed latencies of ABR in 
children given sevoflurane.  Norrix and colleagues (2012) found ABR Wave I and III 
latencies to be very similar between the unanesthetized control and anesthesia 
groups, while Wave V latencies and interpeak intervals (I-III, III-V, I-V) for the 
anesthesia group were delayed compared to those of the control group.   
Likewise, Dubois et al. (1982) studied effects of 1%, 2%, 3% enflurane on the 
human ABR.  Results showed that enflurane consistently produced changes in 
latencies, waves most affected were Waves III, IV, and V, and the magnitude of the 
delay in latency was directly related to the concentration of enflurane, maximum at 
highest concentration of 3%, and reversing itself as the concentration decreased.  
Furthermore, the interpeak latencies were statistically different at concentrations of 
2% and 3%, but not statistically different from control values at 1% enflurane or 
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when patient was waking up, even though they remained elevated.  Amplitude 
effects were not statistically significant.  Interestingly, Stockard & Brickford (1975) 
outlined the depressive effects of enflurane on the brainstem leading to cortical 
epilepsy.   Additionally, animal studies have shown that ABRs may be modified by 
enflurane (Jones et al., 1978).  
Ketamine & Xylazine 
One study using ketamine anesthesia has shown that this agent does not alter ABR 
amplitude, only slightly increases latency, and has no effect on ABR thresholds 
(Smith & Mills, 1989).  Another study using ketamine anesthesia reported an 
increase in CAP threshold and latency at high frequencies (Cazals et al., 1980).  
Further studies have reported ketamine to increase peak latencies in the gerbil and 
rat (Church & Gritzke, 1987; Smith & Mills, 1989, 1991).  Additionally, Van Looij and 
colleagues found anesthesia with a ketamine/xylazine mixture caused a significant 
prolongation of ABR peak and interpeak latencies, as well as a significant increase in 
ABR thresholds as compared to the awake condition.  Similarly, Reubenhausen and 
colleagues (2012) found ABR latencies increased slightly in rat population under 
ketamine/xylazine anesthesia.   
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Chapter 6: Conclusion 
 
Much of the work published on auditory evoked potentials and the effects of 
anesthetics (Dubois et al., 1982; Manninen et al.,1985; Norrix et al., 2012; van Looij 
et al., 2004; Stronks et al., 2010; Reubhausen et al., 2012), supports the finding that 
anesthetic agents, specifically those of the halogenated volatile family influence 
ABRs.  However, some studies (reviewed by Møller, 2011) do not support this 
finding, instead finding that auditory evoked potentials at the level of the brainstem 
are impervious to this group of anesthetic agents.  Animal research studies, 
including those by van Looij et al. (2004), Stronks et al. (2010), and Reubhausen et 
al. (2012), have found isoflurane and ketamine/xylazine anesthesia to affect 
auditory evoked potential thresholds, latencies (van Looij et al., 2004; Stronks et al., 
2010), and amplitude (Stronks et al., 2010).  Additionally, several studies in the 
human population, including those by Dubois et al. (1982), Manninen et al. (1985), 
and Norrix et al. (2012) have reported halogenated volatile anesthetics influencing 
ABR absolute and interpeak latencies.   
Edwards and Kileny (1997) reported that volatile anesthetics may affect ABR 
Wave V or the I-V interpeak latency because of these anesthetic’s ability to depress 
neural activity and cerebral metabolic rate.  Furthermore, a review by Banoub et al. 
(2003) stated that the volatile anesthetics are associated with slight increases in 
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ABR latency due to the depressive affects of these anesthetics on neuronal activity.  
Banoub et al. (2003) point out that the volatile anesthetics slow synaptic neural 
transmission, with these effects being more pronounced on later cortical evoked 
potentials compared to brainstem evoked potentials.  As for the middle latency 
responses, the AMLR, there is ample evidence that general anesthetics, especially 
those of the halogenated volatile family increase the latency and decrease the 
amplitude of the AMLR (Thorton & Sharpe, 1998; Goto et al., 2001) 
Contradictory to these research findings, Møller (2011) states that 
subcortical auditory evoked potentials, including the ABR and CAP recorded from 
the exposed AN are not affected by commonly used anesthetics.  Møller (2011) 
reports that although slight changes in ABR recordings have been found as a result 
of certain anesthesia (Cohen & Britt, 1982; Thorton et al., 1981), the ABR is notably 
insensitive to anesthetic agents.  Møller (2011) goes on to state that any type of 
anesthesia can be considered without any regard to possible negative effects on ABR 
recordings.  Edwards and Kileny (1997) state that the ABR is generally regarded to 
be resistant to effects of pharmacological agents. 
Although a wealth of resources refute the fact that volatile anesthetics and 
other anesthetic agents negatively impact auditory evoked potential recordings, an 
abundance of literature has provided evidence of prolonged ABR latencies, 
decreased ABR amplitudes, and increased thresholds, as well as CAP threshold and 
latency increases and CAP amplitude decreases, and even decreases in the CM 
(Stronks et al., 2010).  Because of the existence of such long-standing evidence to 
support anesthesia inducing effects on auditory evoked potentials, audiologists 
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should be cautious when interpreting ABR data during surgical procedures using 
general anesthesia.    
Though only slight changes to ABR recordings have been reported, 
audiologists performing neurophysiologic intraoperative monitoring should be 
knowledgeable of the types and concentrations of pharmacological agents being 
administered to the patient and the effects of these drugs on the ABR in relation to 
the surgical procedure being performed.  To this end, it is apparent that successful 
NIOM requires a team approach involving steady communication between members 
of the surgical, anesthesiology, and audiological NIOM teams (Galloway, 2010).  
Furthermore, successful NIOM commands the use of general anesthetics, which do 
not significantly alter electrophysiologic signals (Iwasaki et al., 2003) to allow for 
accurate and reliable interpretation.  Therefore, the appropriate choice of anesthetic 
is critical and depends on the underlying medical condition of the patient, the type 
of surgical procedure taking place, and the type of monitoring necessary (Galloway, 
2010).   
In order for the NIOM audiologist to consider all of these factors and 
communicate his/her anesthetic preference to the anesthesiologist based on what 
the surgeon desires to be monitored, the audiologist must be well versed in 
pharmacological effects on the ABR.  Accreditation in NIOM from two organizations, 
the American Board of Neurophysiologic Monitoring (ABNM) and the American 
Board of Registration of Electroencephalographic and Evoked Potential 
Technologists, requires testing in the area of anesthesia effects.  For example, the 
written exam developed by the ABNM is broken down into basic neuroscience 30%, 
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signal acquisition and processing 8%, electroencephalography (EEG) 8%, sensory 
evoked potentials 24%, motor potentials 22%, and effects of anesthesia 8% (ABNM, 
2012).  Although the ABNM requires the studying audiologist to be proficient in 
several areas including the area of anesthesia and its effects on evoked potentials, 
they provide no single reference that can be used in preparation for the 
examination.  Instead, the ABNM provides a list of 23 textbooks and 9 journals they 
recommend as references for study material.  Aside from these publicly available 
materials, the ABNM does not sanction a specifically designed review course or 
study guide for the purpose of its accreditation exam (ABNM, 2012).  For this 
reason, a single book of normative data in the area of anesthesia should be 
developed for the audiologist pursuing a career in NIOM to aid in the study of this 
portion of the examination.  This book should consist of a review of the types and 
classes of anesthetic agents, and a list of those drugs that have been shown to 
influence auditory evoked potentials, including the ABR, as well as other sensory 
evoked potentials and motor potentials.  This book should provide normative data 
of the effects for each drug listed, as well as separate norms accounting for the 
effects of gender, age, and body weight.  This would include different populations, 
such as males versus females, children versus adults, and younger adults versus 
older adults.  This book should also describe the effects of additional physiological 
variables on evoked potentials, including hypothermia, hypotension, anoxia, and 
ischemia.  Ultimately, this book should serve as a complete reference, with all 
relevant anesthetic data compiled in one place and should function as an aggregate 
source for audiologists and those alike whose goal is to practice NIOM.  Overall, 
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audiologists have contributed greatly to the field of NIOM for many years and are 
well qualified due to the training they receive in electrophysiology, clinical data, and 
patient performance (Edwards & Kileny, 1998).  Proficient knowledge of anesthetics 
and their effects on evoked potentials will strengthen the audiologist’s claim to the 
profession of NIOM. 
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